Published in J Clin Diagn Res on March 01, 2016
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant (2003) 1.13
Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12
The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians. Indian J Nephrol (2010) 1.05
Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int (1993) 1.01
Significance of C4d deposition in antibody-mediated rejection. Clin Transplant (2012) 0.94
The classification and treatment of antibody-mediated renal allograft injury: where do we stand? Kidney Int (2007) 0.93
A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int (2014) 0.91
Nonrejection pathology of renal allograft biopsies: 10 years experience from a tertiary care center in north India. Indian J Pathol Microbiol (2012) 0.85
Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? Clin Transplant (2008) 0.82
Percutaneous renal graft biopsy: a clinical, laboratory and pathological analysis. Sao Paulo Med J (1999) 0.81
The importance of C4d in biopsies of kidney transplant recipients. Clin Dev Immunol (2013) 0.79
The impact of C4d and microvascular inflammation before we knew them. Clin Transplant (2013) 0.79